What is the best approach to manage a patient with anxiety, depression, sleep disturbances, pain, and hypertension, taking Alprazolam, Buspirone, Bupropion XL, Zolpidem, Oxycodone/acetaminophen (Percocet), and an antihypertensive medication?

Comprehensive Medication Management for Complex Polypharmacy

Immediate Priority: Discontinue Alprazolam and Zolpidem

This patient's regimen requires urgent deprescribing of alprazolam and zolpidem due to significant safety concerns, particularly cognitive impairment, fall risk, and potential for dependence. 1

Critical Safety Issues with Current Regimen

Alprazolam 2 mg twice daily as needed represents excessive benzodiazepine exposure that increases risks of:

• Cognitive impairment and falls 1
• Respiratory depression when combined with opioids (oxycodone/acetaminophen) 2, 3
• Dependence and withdrawal seizures upon discontinuation 3
• Paradoxical agitation, irritability, and aggressive behavior 3

Zolpidem 10 mg nightly should be prescribed with extreme caution or avoided because hypnotics like zolpidem cause cognitive impairment and increase fall risk, particularly problematic in patients on opioids and benzodiazepines 1

---

Step 1: Transition Anxiety Management

Replace Alprazolam with Optimized Buspirone

Continue buspirone 15 mg twice daily (30 mg total daily) as the primary anxiolytic, as buspirone is already prescribed and represents appropriate first-line therapy for chronic anxiety with cardiovascular disease 1, 4, 5

• Buspirone has low abuse potential, no sedation, no cognitive impairment, and no withdrawal symptoms 4, 5
• Buspirone demonstrates similar anxiolytic efficacy to benzodiazepines but with superior safety profile (16% vs 60-65% drowsiness/lethargy compared to alprazolam/lorazepam) 5
• Buspirone is particularly appropriate for chronic anxiety and mixed anxiety/depression states 4

Alprazolam Taper Protocol

Reduce alprazolam by no more than 0.5 mg every 3 days to prevent withdrawal seizures 3:

• Week 1: Reduce to 1.5 mg twice daily
• Week 2: Reduce to 1 mg twice daily
• Week 3: Reduce to 0.5 mg twice daily
• Week 4: Reduce to 0.25 mg twice daily
• Week 5: Discontinue

Monitor closely for withdrawal symptoms: anxiety, insomnia, irritability, muscle twitching, seizures 3

---

Step 2: Optimize Depression Treatment

Continue Bupropion XL 150 mg Once Daily

Maintain current bupropion XL 150 mg in the morning, but plan to increase to therapeutic dose of 300 mg once daily after 6-8 weeks if inadequate response 6, 2

Critical safety screening before continuing bupropion 1, 6, 2:

• Verify blood pressure is controlled (bupropion can elevate BP, particularly problematic with unspecified antihypertensive) 1, 6
• Confirm no seizure history or conditions lowering seizure threshold 6, 2
• Maximum dose must not exceed 450 mg/day to maintain seizure risk at 0.1% 6, 2

Monitor for efficacy within 6-8 weeks at adequate dose before considering treatment modification 6, 2

Bupropion Advantages for This Patient

• Lower rates of sexual dysfunction compared to SSRIs 6
• Minimal weight gain or potential weight loss 6
• Activating properties beneficial for low energy/apathy 6
• Can address comorbid smoking cessation if applicable 6

---

Step 3: Address Sleep Disturbances

Discontinue Zolpidem and Implement Non-Pharmacological Approaches

Cognitive behavioral therapy for insomnia (CBT-I) is recommended as first-line treatment before initiating sedating medications 1

If Pharmacological Sleep Aid Required

Consider mirtazapine 7.5-15 mg at bedtime as alternative to zolpidem 1:

• Mirtazapine is safe in cardiovascular disease 1
• Provides sleep benefits plus appetite stimulation 1
• Addresses depression and anxiety symptoms 1
• Avoids cognitive impairment and fall risk associated with zolpidem 1

Alternative: Trazodone 25-50 mg at bedtime if mirtazapine causes excessive sedation or weight gain 1

Avoid continuing zolpidem long-term due to cognitive impairment, fall risk, and lack of evidence for chronic use 1

---

Step 4: Optimize Pain Management

Reassess Oxycodone/Acetaminophen Use

Low-dose oral opioids are generally well tolerated for persistent pain, but immediate-release formulations should be used intermittently or as-needed, not scheduled three to four times daily 1

Critical considerations 1:

• Acetaminophen doses of 4 g daily may increase systolic blood pressure in hypertensive patients 1
• Opioid adverse effects (respiratory depression, falls, confusion) are increased with high-dose administration 1
• Combining opioids with benzodiazepines (alprazolam) significantly increases respiratory depression risk 2, 3

Recommended approach:

• Reduce opioid frequency to true as-needed use (not scheduled) 1
• Consider opioids without active metabolites (methadone, buprenorphine, fentanyl) if renal dysfunction present 1
• Explore non-opioid alternatives: topical lidocaine, diclofenac, capsaicin 1
• Consider SSRIs for neuropathic pain component (sertraline preferred in cardiovascular disease) 1

---

Step 5: Monitor Cardiovascular Medications

Antihypertensive Medication Considerations

Verify blood pressure control before continuing/increasing bupropion 1, 6:

• Bupropion can elevate blood pressure and heart rate 1, 6
• Monitor BP and HR periodically, especially first 12 weeks 6
• Uncontrolled hypertension is contraindication for bupropion 1, 6

Assess if antihypertensive contributes to fatigue 1:

• β-blockers and diuretics may cause fatigue 1
• Consider administering at bedtime to avoid daytime drowsiness 1

---

Step 6: Monitoring and Follow-Up Schedule

Week 1-2: Initial Assessment

• Begin alprazolam taper (reduce by 0.5 mg every 3 days) 3
• Discontinue zolpidem, initiate CBT-I or mirtazapine if needed 1
• Monitor for withdrawal symptoms, worsening anxiety, suicidal ideation 2, 3
• Check blood pressure and heart rate 6

Week 4-6: Mid-Point Evaluation

• Complete alprazolam discontinuation 3
• Assess buspirone efficacy for anxiety 4, 5
• Evaluate sleep quality with new regimen 1
• Monitor pain control with reduced opioid frequency 1

Week 6-8: Efficacy Assessment

• Assess bupropion efficacy for depression 6, 2
• Consider increasing bupropion to 300 mg once daily if inadequate response 6
• Evaluate need for continued sleep medication 1
• Reassess overall symptom burden and quality of life 1

Ongoing Monitoring

• Depression symptoms, suicidal ideation (especially if patient <24 years old) 2
• Blood pressure and heart rate 6
• Neuropsychiatric symptoms (agitation, behavioral changes) 2
• Pain severity and functional status 1
• Sleep quality 1

---

Critical Safety Warnings

Black box warning for bupropion: Increased risk of suicidal thoughts and behavior in patients younger than 24 years with depression requires close monitoring, especially during first few months of treatment 2

Seizure risk with bupropion: Maximum dose 450 mg/day (300 mg/day for smoking cessation), avoid in patients with seizure disorders, eating disorders, or abrupt discontinuation of alcohol/benzodiazepines/antiepileptics 6, 2

Benzodiazepine withdrawal: Abrupt discontinuation of alprazolam can cause withdrawal seizures; taper slowly 3

Opioid-benzodiazepine combination: Significantly increases respiratory depression risk; prioritize alprazolam discontinuation 2, 3